|
WO2020147525A1
|
|
Preparation method for morpholinquinazoline compound and midbody thereof
|
|
CN110950844A
|
|
Crystal form of morpholinyl quinazoline compound, preparation method and application thereof
|
|
CN110066276A
|
|
Heteroaromatic compound, wherein mesosome, preparation method, pharmaceutical composition and application
|
|
CN110066277A
|
|
Aromatic heterocycle substituted olefine compound, preparation method, pharmaceutical composition and application
|
|
MX2019001225A
|
|
Nitrogenous heterocyclic aromatic compound, preparation method therefor, pharmaceutical composition thereof, and application thereof.
|
|
CN106478634A
|
|
Condensed imidazole compound, its preparation method, pharmaceutical composition and purposes
|
|
CN108516958A
|
|
Fused-ring derivatives, preparation method, intermediate, pharmaceutical composition and application
|
|
EP3059238A1
|
|
Fused heterocyclic compound, preparation method therefor, pharmaceutical composition, and uses thereof
|
|
WO2015043398A1
|
|
Fused pyrimidine compound, intermediate, preparation method therefor, and composition and application thereof
|
|
EP2940026A1
|
|
Composition of glucose derivative and proline, crystal, preparation method and application
|
|
EP2860181A1
|
|
Fused pyrimidine compound, and preparation method, intermediate, composition and uses thereof
|
|
EP2676965A1
|
|
Aryl glycoside compound, preparation method and use thereof
|
